The treatment, which involves drawing blood and injecting it back several days later with new anti-inflammatory proteins that stimulate cell growth, is designed to treat inflammation as both a cause and symptom of tissue damage in the joints or lower back.
The therapy typically lasts five days, beginning with an evaluation and drawing of blood.
Related Articles on Pain Management:
myoscience Receives FDA Clearance for Pain Management Device
Pain Management Specialist Dr. John Keel Joins New England Baptist Hospital
Opposition Threatens Kentucky Drug Abuse Bill
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
